银纳米颗粒的生物制造使用Nostoc肌肉Lukesova 2/91:优化,表征和生物应用
Reham Samir Hamida1, Mohamed Abdelaal Ali2, Fatima Tariq Sharif3
1Institute for Protein Research, Osaka University, Osaka, 565-0871, Japan.
International journal of nanomedicine
|October 11, 2023
概括
这项研究表明,Nostoc muscorum Lukesova 2/91可以有效地生物合成小,稳定的银纳米粒子 (AgNPs). 这些新型纳米粒子具有显著的抗癌和抗微生物特性,具有环保的治疗潜力.
科学领域:
- 生物技术和纳米技术
- 微生物学 微生物学
- 材料科学 材料科学 材料科学
背景情况:
- 纳米粒子 (NP) 的生物合成为化学方法提供了一个环保,可扩展和生物相容的替代方案.
- 菌,如 *Nostoc muscorum *,是NP生物合成的有希望的微生物,因为它们的广泛性和已被证明的生物工厂的有效性.
- 发现新的微藻菌株来产生小,稳定的NP仍然是一个关键的研究领域.
研究的目的:
- 为了隔离和描述 *Nostoc muscorum* Lukesova 2/91 作为纳米粒子生物合成的潜在来源.
- 使用 *N. muscorum* 藻类提取物优化银纳米颗粒 (AgNPs) 生物合成条件.
- 评估生物合成的银纳米颗粒的抗增殖和抗微生物活性.
主要方法:
- 通过显微镜和DNA测序,将 *Nostoc muscorum* Lukesova 2/91 分离,净化和遗传鉴定.
- 在藻类提取物中分析挥发性生物分子,使用气色谱-质谱 (GC-MS).
- 使用UV-VIS,FTIR,TEM,SEM,EDx,映射和Zetasizer进行银纳米粒子 (Nos@AgNPs) 的生物合成和表征.
主要成果:
- 诺斯@AgNPs生产的最佳条件是:1毫米的AgNO3,1:1的提取物比率,25°C,光,24小时,pH7.4.4.
- 特性No@AgNPs:波长为401.4纳米,立方到圆形,平均直径为11.8±0.5纳米,含银量为86.15%,电荷为19.7mV.
- FTIR分析表明,蛋白质/多糖类对NP合成起到减少剂和稳定剂的作用.
结论:
- *Nostoc muscorum* Lukesova 2/91是一种有效的生物制造小,稳定的银纳米颗粒的来源.
- 生物合成的Nos@AgNPs显示出对肺癌,结肠癌和乳腺癌细胞系的显著抑制活性.
- 诺斯@AgNPs对关键的致病细菌具有相当大的生物杀伤活性,包括金黄色葡萄球菌和大肠杆菌.
更多相关视频
13:02Microfabrication of Nanoporous Gold Patterns for Cell-material Interaction Studies
Published on: July 15, 2013
11.4K
11:19Synthesis of Multi-walled Carbon Nanotubes Modified with Silver Nanoparticles and Evaluation of Their Antibacterial Activities and Cytotoxic Properties
Published on: May 10, 2018
10.3K
相关概念视频
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Production of Antibiotics
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
